A new research bill is on its way. The Alf agreement is in place. There is a major investment in treatment research and broad collaboration for more clinical studies. There is no shortage of money or infrastructure for clinical research in the health sector. The challenge now is to translate these investments into concrete results. Is the health system ready?
Speakers include Arvid Söderhäll, CEO, Empros Pharma and Chair of SwedenBIO’s Clinical Trials and Regulatory Affairs Working Group, and Anna Sandström, Science Relations Manager, Astra Zeneca and Chair of SwedenBIO’s Research and Development Working Group.
SwedenBIO is a co-organizer.
